Data for Naito, 2021, Combined Use of a Polycarboxybetaine Coating and a Selective Factor XII Inhibitor Markedly Reduces Artificial Surface Clot Formation While Preserving Normal Tissue Coagulation During Extracorporeal Life Support

Published: 20 January 2021| Version 1 | DOI: 10.17632/tg8dntkgsc.1
Keith Cook


This data is in support of our study examining the combined use of polycarboxybetaine coatings and FXII inhibition during extracorporeal life support in rabbits.


Steps to reproduce

Please see paper by Naito N., Ukita R., et al.